Latin America Health Times
SEE OTHER BRANDS

Keeping up with healthcare and wellness news from Latin America

Latin America Health Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Latin America Health Times.

Press releases published on May 15, 2025

Biohackers World Conference & Expo Comes to Chicago, Exploring the Future of Health and Human Performance

Biohackers World Conference & Expo Comes to Chicago, Exploring the Future of Health and Human Performance

Discover the latest in health tech, performance tools, and longevity science at Chicago’s two-day event on wellness, biohacking, and human optimization. CHICAGO, IL, UNITED STATES, May 15, 2025 /⁨EINPresswire.com⁩/ -- Biohackers World, a growing …

Shriners Children’s St. Louis Surgeon Dr. J. Eric Gordon Receives Prestigious Humanitarian Award

Shriners Children’s St. Louis Surgeon Dr. J. Eric Gordon Receives Prestigious Humanitarian Award

Shriners Children’s St. Louis Orthopedic Surgeon J. Eric Gordon, MD, has received the prestigious Humanitarian Award. ST. LOUIS, MO, UNITED STATES, May 15, 2025 /⁨EINPresswire.com⁩/ -- Shriners Children’s St. Louis is proud to announce that Orthopedic …

Dr. Mayank Agarwal Now Seeing Patients at Modern Heart and Vascular Institute’s New Spring Clinic

Dr. Mayank Agarwal Now Seeing Patients at Modern Heart and Vascular Institute’s New Spring Clinic

Dr. Mayank Agarwal Now Seeing Patients at Modern Heart and Vascular Institute’s New Spring Clinic SPRING, TX, UNITED STATES, May 15, 2025 /⁨EINPresswire.com⁩/ -- Dr. Mayank Agarwal is now seeing patients at Modern Heart and Vascular Institute's new clinic …

InstantGMP PRO, Ahora disponible en Español, ampliando Soluciones de normas GMP para Fabricantes Internacionales

InstantGMP PRO, Ahora disponible en Español, ampliando Soluciones de normas GMP para Fabricantes Internacionales

CARY, NC, UNITED STATES, May 15, 2025 /⁨EINPresswire.com⁩/ -- InstantGMP™, proveedor líder de soluciones tecnológicas para industrias reguladas, anunció hoy que su plataforma insignia, InstantGMP PRO™, ya está disponible en español, ofreciendo así …

Ancient Biblical Remedies Under Review: Ancient Lost Remedies Revived with Hidden Healing Secret Remedies of the Scriptures

Ancient Biblical Remedies Under Review: Ancient Lost Remedies Revived with Hidden Healing Secret Remedies of the Scriptures

New York, May 15, 2025 (GLOBE NEWSWIRE) -- In This Article, You’ll Discover: How The Encyclopedia of Natural Remedies by 365 Daily Health unveils ancient biblical remedies drawn from scripture Why chronic health issues like inflammation, fatigue, and …

FuturHealth Under Review: Best GLP-1 Semaglutide Medication Prescription for Weight Loss with No Insurance

FuturHealth Under Review: Best GLP-1 Semaglutide Medication Prescription for Weight Loss with No Insurance

San Diego, May 15, 2025 (GLOBE NEWSWIRE) -- In This Article, You’ll Discover: Why millions of Americans are turning to GLP-1 semaglutide prescriptions for weight loss without insurance The top pain points consumers face in traditional weight loss and …

HCW Biologics Reports First Quarter 2025 Business Highlights and Financial Results

HCW Biologics Reports First Quarter 2025 Business Highlights and Financial Results

MIRAMAR, Fla., May 15, 2025 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the “Company” or “HCW Biologics”) (NASDAQ: HCWB), a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen health span by …

Moody's Investor Services Upgrades Teva Amid Continued Success of Pivot to Growth Strategy

Moody's Investor Services Upgrades Teva Amid Continued Success of Pivot to Growth Strategy

TEL AVIV, Israel, May 15, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals (NYSE and TASE: TEVA) today announced that Moody's Investor Services (“Moody's”) has raised the company's corporate credit rating to Ba1, outlook stable; from Ba2, outlook positive. …

BioSyent Releases Financial Results for First Quarter 2025

BioSyent Releases Financial Results for First Quarter 2025

MISSISSAUGA, Ontario, May 15, 2025 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today its financial results for the first quarter (Q1) ended March 31, 2025. Key highlights include: (CAD) Q1 2025 % Change vs. Q1 2024 Trailing …

BioSyent Declares Second Quarter 2025 Dividend

BioSyent Declares Second Quarter 2025 Dividend

MISSISSAUGA, Ontario, May 15, 2025 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce that its Board of Directors has declared a quarterly dividend of $0.05 per common share, payable in Canadian Dollars on …

Biofrontera Inc. Reports First Quarter 2025 Financial Results and Provides a Business Update

Biofrontera Inc. Reports First Quarter 2025 Financial Results and Provides a Business Update

Conference call begins at 10:00 a.m. Eastern time on Friday, May 16, 2025 WOBURN, Mass., May 15, 2025 (GLOBE NEWSWIRE) -- Biofrontera Inc. (NASDAQ:BFRI) (the "Company"), a biopharmaceutical company specializing in the commercialization of dermatologic …

Shuttle Pharma Provides Corporate Update

Shuttle Pharma Provides Corporate Update

GAITHERSBURG, Md., May 15, 2025 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma” or the “Company”), a discovery and development stage specialty pharmaceutical company focused on improving outcomes for cancer …

Rakovina Therapeutics Announces Strategic Private Placement, Convertible Debt Financing, and Share Consolidation to Accelerate US-Focused Growth and AI-Powered Oncology Innovation

Rakovina Therapeutics Announces Strategic Private Placement, Convertible Debt Financing, and Share Consolidation to Accelerate US-Focused Growth and AI-Powered Oncology Innovation

VANCOUVER, British Columbia, May 15, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO) (“Rakovina” or the “Company”), a biopharmaceutical company advancing innovative cancer therapies through artificial intelligence (AI)-powered …

60 Degrees Pharmaceuticals Announces First Quarter 2025 Results

60 Degrees Pharmaceuticals Announces First Quarter 2025 Results

Q1 2024 net product revenues increased 55% year-over-year to $163.6 thousand. Gross profit increased 124% to $90.3 thousand. WASHINGTON, May 15, 2025 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (the “Company”), a …

Combined General Meeting of June 11, 2025

Combined General Meeting of June 11, 2025

Châtillon, France, May 15, 2025 Combined General Meeting of June 11, 2025 Procedures for Obtaining Information and Preparatory Documents for the Combined General Meeting DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a …

Assemblée Générale Mixte du 11 juin 2025

Assemblée Générale Mixte du 11 juin 2025

Châtillon, France, le 15 mai 2025 Assemblée Générale Mixte du 11 juin 2025 Modalités de mise à disposition des informations et documents préparatoires à l’Assemblée Générale Mixte DBV Technologies (Euronext : DBV – ISIN : FR0010417345 – Nasdaq Stock Market …

Hapbee Technologies Teams Up with Liberty Alliance to Deliver Wearable Sleep and Performance Technology to the Defense Sector; Updates Status of Audited Financial Statements

Hapbee Technologies Teams Up with Liberty Alliance to Deliver Wearable Sleep and Performance Technology to the Defense Sector; Updates Status of Audited Financial Statements

VANCOUVER, British Columbia, May 15, 2025 (GLOBE NEWSWIRE) -- Hapbee Technologies, Inc. (TSXV: HAPB | OTCQB: HAPBF), a leading provider of wearable wellness technology, is proud to announce it has teamed up with Liberty Alliance, a veteran-owned business ( …

Precision Optics Reports Third Quarter Fiscal Year 2025 Financial Results

Precision Optics Reports Third Quarter Fiscal Year 2025 Financial Results

GARDNER, Mass., May 15, 2025 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (NASDAQ: POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense/aerospace industries, announced operating results on an …

Globus Medical Announces $500 Million Share Repurchase Program

Globus Medical Announces $500 Million Share Repurchase Program

AUDUBON, Pa., May 15, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced that its Board of Directors has authorized a share repurchase program of up to $500 million of the Company’s …

SCYNEXIS Reports First Quarter 2025 Financial Results and Provides Corporate Update

SCYNEXIS Reports First Quarter 2025 Financial Results and Provides Corporate Update

Ibrexafungerp clinical hold lifted by the FDA. SCYNEXIS working to resolve a disagreement with GSK involving the restart of the MARIO study. GSK remains committed to the commercialization of Brexafemme. Hansoh recently received Chinese (NMPA) approval for …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service